Drug Trial Radar · NCT07358377
A Trial of HRS-6209-205 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-6209 in Combination Therapy in Subjects With HR-Positive/HER2-Negative Cancer
Last checked: Nov 20, 2026Latest source record: Aug 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
15
Planned (sponsor's estimate)
Start
May 15, 2026
Primary completion
Apr 10, 2027
Study completion Nov 10, 2027
Sponsor
- Lead sponsor
- Atridia Pty Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jan 22, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-6209 in Subjects with HR-Positive/HER2-Negative solid tumor.
Conditions
- Breast Cancer
Interventions
HRS-6209 Capsules and fulvestrant injectionDrug
HRS-6209, 100mg BID for 4 weeks, and single dose of fulvestrant injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety by reporting incidence and severity of Adverse events (graded as per CTCAE V5.0) of adverse events (AEs) and serious adverse events (SAEs),Time frame: Screening up to study completion,, an average of 1 year.
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Southern Highlands Private Hospital
Bowral, New South Wales, Australia · Recruiting
GenesisCare St Leonards
Sydney, New South Wales, Australia · Recruiting
GenesisCare Frenchs Forest
Sydney, New South Wales, Australia · Recruiting
Lyell McEwin Hospital
Elizabeth Vale, South Australia, Australia · Recruiting
Ballarat Base Hospital
Ballarat, Victoria, Australia · Recruiting
Frankston Hospital
Frankston, Victoria, Australia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.